Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (117)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Cools, R.
Right arrow Articles by Owen, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cools, R.
Right arrow Articles by Owen, A. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain, Vol. 125, No. 3, 584-594, March 2002
© 2002 Guarantors of Brain

Dopaminergic modulation of high-level cognition in Parkinson’s disease: the role of the prefrontal cortex revealed by PET

Roshan Cools1, Elka Stefanova4, Roger A. Barker2, Trevor W. Robbins1 and Adrian M. Owen3

1 Department of Experimental Psychology, University of Cambridge, Cambridge, 2 Cambridge Centre for Brain Repair and Department of Neurology, University of Cambridge, 3 MRC Cognition and Brain Sciences, Cambridge, UK and 4 Institute of Neurology, Dr Subotica 6, Belgrade, Yugoslavia

Correspondence to: Roshan Cools, C.D. Marsden Parkinson’s Disease Society Research Student, Department of Experimental Psychology, University of Cambridge, Downing Site, Cambridge CB2 3EB, UK E-mail: rc245{at}cam.ac.uk

This study examined the effects of L-dopa medication in patients with Parkinson’s disease on cortical and subcortical blood flow changes during two tasks known to involve frontostriatal circuitry. Eleven patients with Parkinson’s disease were scanned on two occasions, one ON L-dopa medication and one OFF L-dopa medication, during performance of the Tower of London planning task and a related test that emphasized aspects of spatial working memory. L-dopa-induced decreases were observed in the right dorsolateral prefrontal cortex during performance of both the planning and the spatial working memory tasks compared with the visuomotor control task. Conversely, L-dopa-induced blood flow increases were observed in the right occipital lobe during the memory task relative to the control task. Data from age-matched healthy volunteers demonstrated that L-dopa effectively normalized blood flow in these regions in the patient group. Moreover, a significant correlation was found between L-dopa-induced, planning related blood flow decreases in the right dorsolateral prefrontal cortex and L-dopa-induced changes in performance on the planning task. These data suggest that L-dopa ameliorates high-level cognitive deficits in Parkinson’s disease by inducing relative blood flow changes in the right dorsolateral prefrontal cortex.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Neurosci.Home page
C. A. Dockery, R. Hueckel-Weng, N. Birbaumer, and C. Plewnia
Enhancement of Planning Ability by Transcranial Direct Current Stimulation
J. Neurosci., June 3, 2009; 29(22): 7271 - 7277.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
D. A. Copland, K. L. McMahon, P. A. Silburn, and G. I. de Zubicaray
Dopaminergic Neuromodulation of Semantic Processing: A 4-T fMRI Study with Levodopa
Cereb Cortex, March 25, 2009; (2009) bhp017v1.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J.-C. Dreher, A. Meyer-Lindenberg, P. Kohn, and K. F. Berman
From the Cover: Age-related changes in midbrain dopaminergic regulation of the human reward system
PNAS, September 30, 2008; 105(39): 15106 - 15111.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
J. B. Rowe, L. Hughes, B. C. P. Ghosh, D. Eckstein, C. H. Williams-Gray, S. Fallon, R. A. Barker, and A. M. Owen
Parkinson's disease and dopaminergic therapy--differential effects on movement, reward and cognition
Brain, August 1, 2008; 131(8): 2094 - 2105.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. A. B. Wisman, G. Sahin, M. Maingay, G. Leanza, and D. Kirik
Functional Convergence of Dopaminergic and Cholinergic Input Is Critical for Hippocampus-Dependent Working Memory
J. Neurosci., July 30, 2008; 28(31): 7797 - 7807.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
N. Sawamoto, P. Piccini, G. Hotton, N. Pavese, K. Thielemans, and D. J. Brooks
Cognitive deficits and striato-frontal dopamine release in Parkinson's disease
Brain, May 1, 2008; 131(5): 1294 - 1302.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
B. H. Schott, L. Niehaus, B. C. Wittmann, H. Schutze, C. I. Seidenbecher, H.-J. Heinze, and E. Duzel
Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing
Brain, September 1, 2007; 130(9): 2412 - 2424.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
C. H. Williams-Gray, A. Hampshire, T. W. Robbins, A. M. Owen, and R. A. Barker
Catechol O-Methyltransferase val158met Genotype Influences Frontoparietal Activity during Planning in Patients with Parkinson's Disease
J. Neurosci., May 2, 2007; 27(18): 4832 - 4838.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
O. Monchi, M. Petrides, B. Mejia-Constain, and A. P. Strafella
Cortical activity in Parkinson's disease during executive processing depends on striatal involvement
Brain, January 1, 2007; 130(1): 233 - 244.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. H. Schott, C. I. Seidenbecher, D. B. Fenker, C. J. Lauer, N. Bunzeck, H.-G. Bernstein, W. Tischmeyer, E. D. Gundelfinger, H.-J. Heinze, and E. Duzel
The Dopaminergic Midbrain Participates in Human Episodic Memory Formation: Evidence from Genetic Imaging
J. Neurosci., February 1, 2006; 26(5): 1407 - 1417.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
E. Y. Uc, M. Rizzo, S. W. Anderson, S. Qian, R. L. Rodnitzky, and J. D. Dawson
Visual dysfunction in Parkinson disease without dementia
Neurology, December 27, 2005; 65(12): 1907 - 1913.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
A L Cheesman, R A Barker, S J G Lewis, T W Robbins, A M Owen, and D J Brooks
Lateralisation of striatal function: evidence from 18F-dopa PET in Parkinson's disease
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1204 - 1210.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S J G Lewis, T Foltynie, A D Blackwell, T W Robbins, A M Owen, and R A Barker
Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach
J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 343 - 348.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
A. M. Owen
Cognitive Dysfunction in Parkinson's Disease: The Role of Frontostriatal Circuitry
Neuroscientist, December 1, 2004; 10(6): 525 - 537.
[Abstract] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
D. J. Burn and A. I. Troster
Neuropsychiatric Complications of Medical and Surgical Therapies for Parkinson's Disease
J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 172 - 180.
[Abstract] [PDF]


Home page
BrainHome page
T. Foltynie, C. E. G. Brayne, T. W. Robbins, and R. A. Barker
The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study
Brain, March 1, 2004; 127(3): 550 - 560.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. A. Castner and P. S. Goldman-Rakic
Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation
J. Neurosci., February 11, 2004; 24(6): 1446 - 1450.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
O. Monchi, M. Petrides, J. Doyon, R. B. Postuma, K. Worsley, and A. Dagher
Neural Bases of Set-Shifting Deficits in Parkinson's Disease
J. Neurosci., January 21, 2004; 24(3): 702 - 710.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
I. K. Goerendt, A. D. Lawrence, and D. J. Brooks
Reward Processing in Health and Parkinson's Disease: Neural Organization and Reorganization
Cereb Cortex, January 1, 2004; 14(1): 73 - 80.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. J. G. Lewis, A. Dove, T. W. Robbins, R. A. Barker, and A. M. Owen
Cognitive Impairments in Early Parkinson's Disease Are Accompanied by Reductions in Activity in Frontostriatal Neural Circuitry
J. Neurosci., July 16, 2003; 23(15): 6351 - 6356.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Chudasama, C. Baunez, and T. W. Robbins
Functional Disconnection of the Medial Prefrontal Cortex and Subthalamic Nucleus in Attentional Performance: Evidence for Corticosubthalamic Interaction
J. Neurosci., July 2, 2003; 23(13): 5477 - 5485.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
A. Feigin, M. F. Ghilardi, M. Carbon, C. Edwards, M. Fukuda, V. Dhawan, C. Margouleff, C. Ghez, and D. Eidelberg
Effects of levodopa on motor sequence learning in Parkinson's disease
Neurology, June 10, 2003; 60(11): 1744 - 1749.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. S. Mattay, T. E. Goldberg, F. Fera, A. R. Hariri, A. Tessitore, M. F. Egan, B. Kolachana, J. H. Callicott, and D. R. Weinberger
Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine
PNAS, May 13, 2003; 100(10): 6186 - 6191.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
L. Escola, Th. Michelet, F. Macia, D. Guehl, B. Bioulac, and P. Burbaud
Disruption of information processing in the supplementary motor area of the MPTP-treated monkey: A clue to the pathophysiology of akinesia?
Brain, January 1, 2003; 126(1): 95 - 114.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.